Abstract:Background— We explored the relationship of genetic variants of the serotonin transporter gene SLC6A4 , a key regulator of the serotonergic neurotransmission, with both depressive symptoms and plasma interleukin-6 (IL-6) levels. Methods and Results— We genotyped 20 polymorphisms in 360 male twins (mean age, 54 years) from the Vietnam Era Twin Registry. Current depressive symptoms were measured with the Beck Depression Inventory II. IL-6 was assessed using a commercially available ELISA kit. Genotype associations were analyzed using generalized estimating equations. To study how SLC6A4 genetic vulnerability influences the relationship between depressive symptoms and IL-6, bivariate models were constructed using structural equation modeling. Of the 20 polymorphisms examined, the effective number of independent tests was 6, and the threshold of significance after Bonferroni correction was 0.008. There were 6 single-nucleotide polymorphisms significantly associated with Beck Depression Inventory ( P ≤0.008), including rs8071667, rs2020936, rs25528, rs6354, rs11080122, and rs8076005, and 1 single-nucleotide polymorphism was borderline associated (rs12150214, P =0.017). Of these 7 single-nucleotide polymorphisms, 3 were also significantly associated with IL-6 ( P <0.008), including rs25528, rs6354, and rs8076005, and the other 4 were borderline associated ( P =0.009 to 0.025). The subjects with 1 copy of the minor allele of these 7 single-nucleotide polymorphisms had higher Beck Depression Inventory scores and IL-6 levels. Further bivariate modeling revealed that ≈10% of the correlation between Beck Depression Inventory and IL-6 could be explained by the SLC6A4 gene. Conclusions— Genetic vulnerability involving the SLC6A4 gene is significantly associated with both increased depressive symptoms and elevated IL-6 plasma levels. Common pathophysiological processes may link depression and inflammation, and implicate the serotonin pathway in neural-immune interactions.

Serotonin Transporter Gene Polymorphism in Chinese Patients with Poststroke Depression

Serotonin Transporter Gene 5-HTTLPR Polymorphism As a Protective Factor Against the Progression of Post-Stroke Depression.

Association of serotonin transporter gene (SLC6A4) polymorphisms with schizophrenia susceptibility and symptoms in a Chinese-Han population

5-Htr1a And 5-Htr2a Genetic Polymorphisms And Ssri Antidepressant Response In Depressive Chinese Patients

Tentative Association of the Serotonin Transporter with Schizophrenia and Unipolar Depression but Not with Bipolar Disorder in Han Chinese.

Association Study of Serotonin Transporter SLC6A4 Gene with Chinese Han Irritable Bowel Syndrome

Association of unipolar depression with gene polymorphisms in the serotonergic pathways in Han Chinese.

Serotonin Transporter Gene (SLC6A4) Polymorphism May Be Associated with Chinese Globus Pharyngeus and Its Antidepressant Effects

A longitudinal study of SLC6A4 DNA promoter methylation and poststroke depression

Relationship Between Suicidal Behavior of Psychotic Inpatients and Serotonin Transporter Gene in Han Chinese

Association of Polymorphisms of the Serotonin Transporter Gene SLC6A4 with Depression

Slc17a7 Gene May Be The Indicator Of Selective Serotonin Reuptake Inhibitor Treatment Response In The Chinese Han Population

Serotonin Transporter Gene, Depressive Symptoms, and Interleukin-6

Study on the relationship between serotonin receptor 2A gene polymorphism and clinical response to paroxetine

[The association of polymorphisms of the serotonin transporter gene SLC6A4 with depression]

Effects of serotonin transporter and receptor polymorphisms on depression

Effects of Polymorphisms of Serotonin Transporter Promoter (5-HTTLPR) and Brain Derived Neurotrophic Factor Gene (G196A Rs6265) on the Risk of Major Depressive Disorder in the Chinese Han Population.

Association Study of 5-HT1A, 5-HT2A Polymorphisms with Schizophrenia and Major Depressive Disorder in the Han Chinese Population.

No Association Between <i>SLC6A4</i> Gene Polymorphisms With Treatment Remission to Venlafaxine in Han Chinese Depressive Patients

No Association Between SLC6A4 Gene Polymorphisms With Treatment Remission to Venlafaxine in Han Chinese Depressive Patients